These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32665972)

  • 1. Cryoballoon ablation for treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy.
    Alzoubaidi D; Hussein M; Sehgal V; Makahamadze C; Magee CG; Everson M; Graham D; Sweis R; Banks M; Sami SS; Novelli M; Lovat L; Haidry R
    Endosc Int Open; 2020 Jul; 8(7):E891-E899. PubMed ID: 32665972
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign.
    Cameron GR; Desmond PV; Jayasekera CS; Amico F; Williams R; Macrae FA; Taylor AC
    Endosc Int Open; 2016 Aug; 4(8):E849-58. PubMed ID: 27540572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circumferential and focal ablation of Barrett's esophagus containing dysplasia.
    Sharma VK; Jae Kim H; Das A; Wells CD; Nguyen CC; Fleischer DE
    Am J Gastroenterol; 2009 Feb; 104(2):310-7. PubMed ID: 19174783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.
    Orman ES; Li N; Shaheen NJ
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1245-55. PubMed ID: 23644385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
    Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.
    Johnson CS; Louie BE; Wille A; Dunst CM; Worrell SG; DeMeester SR; Reynolds J; Dixon J; Lipham JC; Lada M; Peters JH; Watson TJ; Farivar AS; Aye RW
    J Gastrointest Surg; 2015 May; 19(5):799-805. PubMed ID: 25740341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Canto MI; Shaheen NJ; Almario JA; Voltaggio L; Montgomery E; Lightdale CJ
    Gastrointest Endosc; 2018 Sep; 88(3):438-446.e2. PubMed ID: 29626424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus.
    Greenwald BD; Dumot JA; Horwhat JD; Lightdale CJ; Abrams JA
    Dis Esophagus; 2010 Jan; 23(1):13-9. PubMed ID: 19515183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue.
    Bowman CJ; Zhang R; Balitzer D; Wang D; Rabinovitch PS; Kővári BP; Mattis AN; Kakar S; Lauwers GY; Choi WT
    Mod Pathol; 2021 Oct; 34(10):1889-1900. PubMed ID: 34108638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
    Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Krishnadath KK; Ten Kate F; Fockens P; Bergman JJ
    Endoscopy; 2008 May; 40(5):359-69. PubMed ID: 18494131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
    Wolfson P; Ho KMA; Wilson A; McBain H; Hogan A; Lipman G; Dunn J; Haidry R; Novelli M; Olivo A; Lovat LB;
    Gastrointest Endosc; 2022 Aug; 96(2):223-233. PubMed ID: 35189088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radio frequency ablation of dysplastic Barrett's esophagus: Outcomes of a single-center registry.
    Mathiesen M; Holm J; Thorsteinsson M
    Scand J Surg; 2023 Jun; 112(2):86-90. PubMed ID: 36756673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.